<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80689">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02011347</url>
  </required_header>
  <id_info>
    <org_study_id>2012/26</org_study_id>
    <nct_id>NCT02011347</nct_id>
  </id_info>
  <brief_title>Ketamine and Closed-Loop Anesthesia System</brief_title>
  <acronym>LoopKeta</acronym>
  <official_title>Influence of Ketamine on a Closed-Loop Anesthesia System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to evaluate the sparing effect of ketamine on the dose of propofol.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>administered dose of propofol during maintenance of anesthesia</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>bispectral index measurement</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>bispectral index modification due to ketamine infusion before induction of anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>administered dose of propofol during induction of anesthesia</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>administered doses of remifentanil during induction and maintenance of anesthesia</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>delay (measured as minutes) between the end of propofol and remifentanil administration and the recovery from anesthesia</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemodynamic abnormalities requiring treatment</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of time with a bispectral index between 40 and 60</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative morphine requirement</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of postoperative nausea and vomiting</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>White and Song score</measure>
    <time_frame>day 1</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of patients with an explicit memorisation of the intraoperative period</measure>
    <time_frame>second postoperative day</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive a closed-loop administration of propofol and remifentanil according to bispectral level and Ketamine (bolus dose of Ketamine (1.5 mg.kg-1) followed by an infusion of Ketamine (2 mg.kg-1 h-1) until the end of anesthesia)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive a closed-loop administration of propofol and remifentanil according to bispectral level and a placebo (NaCl 9/00 (same volume as in the Ketamine group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <arm_group_label>Ketamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with an American Society of Anesthesiology score 1, 2 or 3

          -  scheduled for a surgical procedure lasting more than 2 hours under general anesthesia

        Exclusion Criteria:

          -  pregnancy

          -  chronic pain

          -  simultaneous general and loco-regional anesthesia

          -  contra-indication to to nonsteroidal anti-inflammatory drug

          -  contra-indication to Ketamine

          -  contra-indication to propofol, to remifentanil, to morphine

          -  history of central nervous system disease

          -  patients receiving a psychotropic treatment

          -  patients with a pace-maker
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Fischler, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Foch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc Fischler</last_name>
    <phone>46252442</phone>
    <phone_ext>00331</phone_ext>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <state>Hauts de Seine</state>
        <zip>92151</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Chazot, MD</last_name>
      <phone>46252442</phone>
      <phone_ext>00331</phone_ext>
      <email>t.chazot@hopital-foch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Fontaine les Dijons</name>
      <address>
        <city>Fontaine les Dijon</city>
        <zip>21121</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yann Cimino, MD</last_name>
      <phone>0826 30 48 48</phone>
      <email>yanncimino@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 10, 2013</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
